產(chǎn)品名稱 MJN110
產(chǎn)品貨號(hào) Axon 2580 CAS [1438416-21-7] MF C22H21Cl2N3O4MW 462.33 Purity: 98% Soluble in DMSO Description Potent, selective, and in-vivo-active MAGL inhibitor (IC50 values 9.5 nM and 260 nM for inhibition of mouse MAGL and ABHD6, respectively) displaying strong antihyperalgesic activity (mechanical allodynia) in a rat model of diabetic neuropathy. MJN110 exhibits therapeutic potential in the treatment of acute nausea and vomiting as well as anticipatory nausea by elevation of endogenous cannabinoid 2-arachidonoylglycerol (2-AG) levels in the brain. KEYWORDS: MJN110 | supplier | MAGL inhibitor ?| MJN-110 | CAS [1438416-21-7] | 2-arachidonoyl glycerol | 2-AG | MAGL | Inhibitor | endo-cannabinoid | ABHD6 | antihyperalgesic | allodynia | diabetic neuropathy | nausea | vomiting
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

MJN110

Based on 56 reference(s) in Google Scholar 9 10 56

Axon 2580

CAS [1438416-21-7]

MF C22H21Cl2N3O4
MW 462.33

  • Purity: 98%
  • Soluble in DMSO

MJN110

Description

Potent, selective, and in-vivo-active MAGL inhibitor (IC50 values 9.5 nM and 260 nM for inhibition of mouse MAGL and ABHD6, respectively) displaying strong antihyperalgesic activity (mechanical allodynia) in a rat model of diabetic neuropathy. MJN110 exhibits therapeutic potential in the treatment of acute nausea and vomiting as well as anticipatory nausea by elevation of endogenous cannabinoid 2-arachidonoylglycerol (2-AG) levels in the brain.

KEYWORDS: MJN110 | supplier | MAGL inhibitor ?| MJN-110 | CAS [1438416-21-7] | 2-arachidonoyl glycerol | 2-AG | MAGL | Inhibitor | endo-cannabinoid | ABHD6 | antihyperalgesic | allodynia | diabetic neuropathy | nausea | vomiting

產(chǎn)品資料